$16.35 EPS Masks a Sweeping Restructuring Year at Scale (UNH Q4 2025 Earnings Call)
Export as clean Markdown. Drag & drop into ChatGPT, Claude, or Gemini.
UnitedHealth Group delivered a fiscal 2025 that paired steady execution against its long-term strategy with a sweeping internal restructuring designed to reset the foundation for multi-year earnings recovery. The company reported adjusted earnings per share of $16.35, slightly ahead of expectations, while absorbing a $1.6 billion net charge principally tied to restructuring Optum's portfolio. Management guided 2026 adjusted EPS to greater than $17.75, representing at least 8.6% growth, as margin recovery across UnitedHealthcare and operational improvements within Optum begin to compound.
Revenue Hits $448B as Medical Care Ratio Lands Below Expectations
UnitedHealth Group generated full-year revenues of nearly $448 billion, reflecting 12% growth driven by domestic membership expansion of over 415,000 people. The full-year medical care ratio of 89.1% came in slightly better than expectations, though it included approximately 20 basis points of negative impact from charge-related items. The operating cost ratio of 13.3% was slightly elevated due to 40 basis points of charge impacts, including $800 million in broad-based employee incentives and UnitedHealth Foundation funding. Cash flows reached $19.7 billion, approximately 1.5 times net income. The $1.6 billion net charge comprised three components: $800 million for cyber attack-related collection true-ups, a $440 million net gain from portfolio optimization, and $2.5 billion in broad restructuring including a $625 million lost contract reserve for structurally unprofitable third-party relationships.
2026 Guidance Targets $17.75+ EPS with UHC Leading the Recovery
Management set 2026 revenue expectations at approximately $440 billion with adjusted EPS of greater than $17.75. UnitedHealthcare expects roughly 13% adjusted operating earnings growth, principally from commercial and Medicare margin improvement, expanding operating margins by 40 basis points. Tim Noel confirmed Medicare Advantage membership contraction of 1.3 to 1.4 million members for 2026, greater than originally anticipated due to competitive dynamics during the annual enrollment period, but consistent with a deliberate strategy that favored margin recovery. Medicare margins are expected to improve approximately 50 basis points from 2025. Noel called the 2027 advance notice "disappointing," warning it represents a third consecutive year of funding reductions totaling $130 billion and risks "profoundly negative" impacts on seniors' benefits and access.
OptumHealth Narrows Its Network by 20% to Rebuild Value-Based Care
Optum enters 2026 projecting adjusted earnings growth across all three segments, ranging from low to high single digits with margin expansion of 20 to 90 basis points. OptumHealth made the most dramatic changes, narrowing its affiliated provider network by nearly 20%, streamlining risk membership by approximately 15%, and consolidating from 18 electronic medical record systems down to three. CEO Patrick Conway described a "back to basics" focus on integrated value-based care, noting that practices operating in the fully integrated model drive total cost of care down by up to 30% with patient satisfaction NPS near 90. Management realigned Optum Financial Services into OptumInsight to combine healthcare technology and fintech capabilities, targeting real-time point-of-care approval and monetization.
OptumRx Wins 800 New Clients on Transparency Pivot
OptumRx delivered a strong external selling season, implementing and expanding over 800 new customer relationships. The segment offset UnitedHealthcare membership contraction by backfilling more than half of the lost volume. Over 95% of OptumRx customers elected full rebate pass-through in 2026, with all remaining customers expected to transition by 2027. The business removed reauthorization requirements for over 180 drugs, reducing overall prior authorization volume by 10%. CFO Wayne DeVeydt confirmed roughly two-thirds of full-year earnings will be generated in the first half, consistent with 2025 seasonality, driven by Part D benefit design changes under the Inflation Reduction Act.